Mycobacterium bovis is a bacterium belonging to the Mycobacterium tuberculosis complex, known for causing bovine tuberculosis in cattle. This pathogen can also infect a wide range of mammals, including humans, leading to zoonotic transmission. Bovine tuberculosis poses a significant threat to livestock industries and has public health implications due to the potential transmission to humans through consumption of contaminated dairy products or direct contact with infected animals. In humans, M. bovis infection can result in pulmonary and extrapulmonary tuberculosis. Control measures for M. bovis include testing and culling infected animals, pasteurization of milk to reduce transmission through dairy products, and vaccination programs in some regions. The Bacillus Calmette-Guérin (BCG) vaccine, initially developed to protect against Mycobacterium tuberculosis, also provides partial protection against M. bovis. M. bovis has a complex genome, and understanding its virulence factors and mechanisms of transmission is essential for developing effective control strategies. Ongoing research focuses on improving diagnostic tools, vaccines, and management practices to mitigate the impact of M. bovis on both animal and human health.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan